NovaQuest Private Equity Buys CoreRx

NovaQuest Private Equity acquired CoreRx, Inc., a Clearwater, FL-based global contract development and manufacturing organization.

The amount of the deal was not disclosed. Goldman Sachs Specialty Lending Group provided debt financing for the transaction. Affiliates of Signet Healthcare Partners, an investor in the company since 2015, will retain a minority position.

Founded in 2006 and led by Todd R. Daviau, President and CEO, CoreRx provides clinical and commercial CDMO services to a wide range of small to mid-sized pharmaceutical and biotech clients. The company offers preformulation, formulation, analytical and stability, clinical manufacturing, commercial manufacturing, and packaging services.

Formed in 2000, NovaQuest Private Equity is an investor in technology and services companies in the life sciences and healthcare sectors.